Form 8-K - Current report:
SEC Accession No. 0001104659-25-045865
Filing Date
2025-05-08
Accepted
2025-05-08 06:50:10
Documents
15
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2514121d1_8k.htm   iXBRL 8-K 28377
2 EXHIBIT 99.1 tm2514121d1_ex99-1.htm EX-99.1 70079
3 GRAPHIC tm2514121d1_ex99-1img001.jpg GRAPHIC 2594
  Complete submission text file 0001104659-25-045865.txt   287740

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zura-20250508.xsd EX-101.SCH 3011
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20250508_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20250508_pre.xml EX-101.PRE 22356
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2514121d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 25923736
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)